1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Biopharmaceutical Analysis & Statistics in North America Countries, November 2016 (p7)

Biopharmaceutical Analysis & Statistics in North America Countries, November 2016 (p7)

181-210 of about 400 reports

Purchase Reports From Reputable Market Research Publishers

Hemophilia A - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Hemophilia A - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hemophilia A – Pipeline Review, H2 2016, provides an overview of the ...

  • Industries : Pathology, Healthcare
  • Countries : United States

Synapse Biomedical Inc - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2016
  • by GlobalData

Summary Synapse Biomedical Inc (SBI) is a medical device company that develops, manufactures and distributes neurostimulation devices for the neurology market. The company’s NeuRx Diaphragm Pacing System ...

  • Countries : United States

Insulin Like Growth Factor 1 Receptor (CD221 or IGF1R or EC 2.7.10.1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • November 2016
  • by Global Markets Direct

Insulin Like Growth Factor 1 Receptor (CD221 or IGF1R or EC 2.7.10.1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Insulin Like Growth Factor 1 Receptor (CD221 or IGF1R or EC 2.7.10.1) ...

  • Industries : Therapy, Cancer, Pharmaceutical, Pathology, Biopharmaceutical
  • Countries : United States

Macular Edema - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Macular Edema - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Macular Edema – Pipeline Review, H2 2016, provides an overview of ...

  • Industries : Therapy, Pharmaceutical, Pathology, Biopharmaceutical
  • Countries : United States

Ankylosing Spondylitis (Bekhterev’s Disease) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ankylosing Spondylitis – Pipeline Review, ...

  • Industries : Pathology, Therapy, Healthcare, Pharmaceutical
  • Countries : United States

Psoriatic Arthritis - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Psoriatic Arthritis - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Psoriatic Arthritis – Pipeline Review, H2 2016, provides an ...

  • Industries : Pathology, Healthcare, Therapy, Pharmaceutical
  • Countries : United States

Provectus Biopharmaceuticals, Inc. (PVCT) - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2016
  • by GlobalData

Summary Provectus Biopharmaceuticals Inc (Provectus), formerly Provectus pharmaceuticals, Inc. is a biopharmaceutical company that develops pharmaceuticals for oncology and dermatology indications. The ...

  • Industries : Biopharmaceutical
  • Countries : United States

Response Biomedical Corporation (RBM) - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2016
  • by GlobalData

Summary Response Biomedical Corp (Response Biomedical) focuses on the research, development, manufacture and marketing of diagnostic technologies for the point-of-care (POC), central-lab testing and on-site ...

  • Industries : Biopharmaceutical
  • Countries : Canada

Biosimilars Education: Addressing a significant unmet need

  • $ 2448
  • Industry report
  • November 2016
  • by Firstword Pharma

Description How to educate stakeholders about biosimilar benefits What information and data do physicians, payers and patients need about biosimilars? benefits As the market expands and new therapeutic ...

  • Industries : Biopharmaceutical, Generic Drug
  • Countries : Europe, United States

Global In Vitro Diagnostics 2010-2016: Deal trends, players, financials and forecasts

  • $ 2995
  • Industry report
  • November 2016
  • by Currentpartnering

The Global In Vitro Diagnostics Partnering 2010-2016 report provides a detailed understanding and analysis of how and why companies enter in vitro diagnostics partnering deals. These deals tend to be ...

  • Industries : Healthcare, Pathology, In Vitro Diagnostics, Diagnostics, Chronic Disease, Health Services
  • Countries : United States

Methionine Aminopeptidase 2 (Initiation Factor 2 Associated 67 kDa Glycoprotein or Peptidase M 2 or eIF 2 Associated p67 Homolog or METAP2 or EC 3.4.11.18) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Methionine Aminopeptidase 2 (Initiation Factor 2 Associated 67 kDa Glycoprotein or Peptidase M 2 or eIF 2 Associated p67 Homolog or METAP2 or EC 3.4.11.18) - Pipeline Review, H2 2016 Summary Global Markets ...

  • Industries : Pathology, Pharmaceutical, Therapy
  • Countries : United States

Ulcerative Colitis - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • October 2016
  • by Global Markets Direct

Ulcerative Colitis - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ulcerative Colitis - Pipeline Review, H2 2016, provides an overview ...

  • Industries : Pathology, Healthcare, Therapy, Pharmaceutical
  • Countries : United States

B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H2 2016

  • $ 2500
  • Company report
  • October 2016
  • by Global Markets Direct

B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H2 2016, ...

  • Industries : Cancer, Pathology, Biotechnology, Biological Therapy
  • Countries : United States

Post Menopausal Osteoporosis - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • October 2016
  • by Global Markets Direct

Post Menopausal Osteoporosis - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Post Menopausal Osteoporosis - Pipeline Review, H2 2016, ...

  • Industries : Chronic Disease, Therapy, Pathology, Pharmaceutical
  • Countries : United States, World

Febrile Neutropenia - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • October 2016
  • by Global Markets Direct

Febrile Neutropenia - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Febrile Neutropenia - Pipeline Review, H2 2016, provides an overview ...

  • Industries : Therapy, Biopharmaceutical, Pharmaceutical
  • Countries : United States, World

Osteoporosis - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • October 2016
  • by Global Markets Direct

Osteoporosis - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Osteoporosis - Pipeline Review, H2 2016, provides an overview of the ...

  • Industries : Chronic Disease, Pathology, Pharmaceutical, Therapy
  • Countries : United States, World

Gastric Cancer - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • October 2016
  • by Global Markets Direct

Gastric Cancer - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gastric Cancer - Pipeline Review, H2 2016, provides an overview of ...

  • Industries : Cancer, Pathology
  • Countries : United States

Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • October 2016
  • by Global Markets Direct

Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline ...

  • Industries : Pathology, Healthcare, Pharmaceutical
  • Countries : United States

Gastroenteritis - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • October 2016
  • by Global Markets Direct

Gastroenteritis - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gastroenteritis - Pipeline Review, H2 2016, provides an overview of ...

  • Industries : Pathology, Therapy, Pharmaceutical
  • Countries : United States

Glycoprotein 41 (gp41) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Glycoprotein 41 (gp41) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Glycoprotein 41 (gp41) - Pipeline Review, H2 2016’, provides in depth analysis on Glycoprotein 41 (gp41) targeted ...

  • Industries : Therapy, Pathology, Pharmaceutical
  • Countries : United States

Hepatitis D - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • October 2016
  • by Global Markets Direct

Hepatitis D - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hepatitis D - Pipeline Review, H2 2016, provides an overview of the Hepatitis ...

  • Industries : Pathology
  • Countries : United States, World

Provectus Biopharmaceuticals, Inc. (PVCT) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2016
  • by GlobalData

Summary Provectus Biopharmaceuticals, Inc. (Provectus), formerly Provectus pharmaceuticals, Inc. is a biopharmaceutical company that develops pharmaceuticals for oncology and dermatology indications. The ...

  • Industries : Biopharmaceutical
  • Countries : United States

Humira Biosimilars Clinical Trial Insight

  • $ 1500
  • Industry report
  • October 2016
  • by PNS Pharma

“Humira Biosimilars Clinical Trial Insight” report by PNS Pharma gives comprehensive clinical insight on 33 biosimilars version of Humira drug in clinical pipeline. More than 10 of these biosimilars ...

  • Industries : Therapy, Biopharmaceutical, Oncology
  • Countries : United States

Alpha Galactosidase A (Alpha D-Galactosidase A or Alpha D Galactoside Galactohydrolase or Melibiase or Agalsidase or GLA or EC 3.2.1.22) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • September 2016
  • by Global Markets Direct

Alpha Galactosidase A (Alpha D-Galactosidase A or Alpha D Galactoside Galactohydrolase or Melibiase or Agalsidase or GLA or EC 3.2.1.22) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Alpha ...

  • Industries : Therapy
  • Countries : Europe, United States, World

Glucosylceramidase (Acid Beta Glucosidase or Alglucerase or D Glucosyl N Acylsphingosine Glucohydrolase or Beta Glucocerebrosidase or Imiglucerase or GBA or EC 3.2.1.45) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • September 2016
  • by Global Markets Direct

Glucosylceramidase (Acid Beta Glucosidase or Alglucerase or D Glucosyl N Acylsphingosine Glucohydrolase or Beta Glucocerebrosidase or Imiglucerase or GBA or EC 3.2.1.45) - Pipeline Review, H2 2016 Summary ...

  • Industries : Biopharmaceutical, Biotechnology, Pathology, Therapy, Pharmaceutical
  • Countries : World, United States, Japan, Israel

Calcitonin Gene Related Peptide (CGRP) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • September 2016
  • by Global Markets Direct

Calcitonin Gene Related Peptide (CGRP) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Calcitonin Gene Related Peptide (CGRP) - Pipeline Review, H2 2016’, provides in depth analysis ...

  • Industries : OTC, Pharmaceutical
  • Countries : United States

Growth Hormone Secretagogue Receptor Type 1 (GH Releasing Peptide Receptor or Ghrelin Receptor or GHSR) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • September 2016
  • by Global Markets Direct

Growth Hormone Secretagogue Receptor Type 1 (GH Releasing Peptide Receptor or Ghrelin Receptor or GHSR) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Growth Hormone Secretagogue Recepto ...

  • Industries : Pharmaceutical, Therapy, Pathology, Biopharmaceutical
  • Countries : United States, World

Molecular Biology Enzymes and Kits & Reagents Market by Product, Application, End User - Trends & Global Forecasts to 2021

  • $ 5650
  • Industry report
  • September 2016
  • by MarketsandMarkets

The molecular biology enzymes and kits & reagents market is projected to reach USD 12.69 billion by 2021 from USD 5.77 billion in 2016, growing at a CAGR of 17.1% during the forecast period of 2016 to ...

  • Industries : Genomics, Biotechnology
  • Countries : World, Asia, Europe, United States, North America

Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2010-2016: Deal trends, players and financials

  • $ 2995
  • Industry report
  • September 2016
  • by Currentpartnering

The Global Cancer Monoclonal Antibody Partnering 2010-2016: Deal trends, players, financials and forecasts report provides an understanding and access to the cancer monoclonal antibody partnering deals ...

  • Industries : Therapy, Cancer, Oncology, Pharmaceutical, Pathology, Biotechnology
  • Countries : United States

Human Cytomegalovirus Envelope Glycoprotein B (gB) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Human Cytomegalovirus Envelope Glycoprotein B (gB) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Human Cytomegalovirus Envelope Glycoprotein B (gB) - Pipeline Review, H2 2016’, provides ...

  • Industries : Pathology, Therapy
  • Countries : United States

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.